NCCN Foundation Announces Awards for Rising Cancer Research Leaders
National Comprehensive Cancer Network s Oncology Research Program to oversee projects from early-career investigators advancing key areas for study in cancer care, such as cancer prevention, racial disparities in screening, immunotherapy, new insights in radiotherapy, and CAR T-cell therapy.
News provided by
Share this article
® today announced six new recipients for the 2021 NCCN Foundation Young Investigator Awards (YIA) Program. The honorees will receive up to $150,000 in funding, over two years, to advance important research on important issues in oncology. These early-career investigators from NCCN Member Institutions represent tomorrow s leaders for advancing cancer care. The NCCN Oncology Research Program (ORP) managed the selection process and will provide guidance and oversight for the projects over the grant duration.
NCCN Foundation announces awards for rising cancer research leaders eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.
The Prostate Cancer Foundation And Cancer Research Innovation In Science Announce 2020 Young Investigator Award Winners
News provided by
Share this article
Share this article
LOS ANGELES, Dec. 16, 2020 /PRNewswire/ The Prostate Cancer Foundation (PCF) and Cancer Research Innovation in Science (CRIS) today announced two new CRIS Cancer Foundation-PCF Young Investigator Awards. The awards, each in the amount of $250,000, are granted to future research leaders at two of the United Kingdom s leading cancer research institutions who will keep the field of prostate cancer research vibrant with new ideas.
Established by the PCF in 2008, the Young Investigator Awards offer career and project support for young (generally 35 and younger), proven investigators in postdoctoral fellowships or who have recently achieved junior faculty positions and are committing their lives to the field of prostate cancer. Each proposal submitted to the PCF undergoes a rigorous peer-review process that a